5-FU Phase 2 (Zyklen 7-12) - MII IG Kerndatensatz-Modul Onkologie v2027.0.0-ballot.1

MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 - Germany

This page is part of the MII IG Kerndatensatz-Modul Onkologie (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Beispiel MedicationStatement: 5-FU Phase 2 (Zyklen 7-12)

German

Profile: MII PR Onkologie Systemische Therapie Medikation

basedOn: CarePlan: identifier = Tumorkonferenz_FOLFOX_Modification_001; status = active; intent = plan; category = prätherapeutische Tumorkonferenz (Festlegung der Therapiestrategie); created = 2024-03-05

partOf: Procedure Nicht komplexe Chemotherapie

status: Completed

medication: 5-Fluorouracil (5-FU)

subject: Martin Beispiel Male, DoB: 1958-11-03

effective: 2024-06-17 --> 2024-09-10

note:

LV5FU2 (modified protocol) - Cycles 7-12

IG © 2022+ Medizininformatik Initiative. Package de.medizininformatikinitiative.kerndatensatz.onkologie#2027.0.0-ballot.1 basiert auf FHIR 4.0.1. Erstellt 2026-09-15
Links: Inhaltsverzeichnis | QA-Bericht | netzwerk-universitaetsmedizin.de | medizininformatik-initiative.de | Impressum
HL7®, FHIR® and the FHIR flame design are registered trademarks of Health Level Seven International. Their use does not constitute endorsement by HL7.